These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344 [TBL] [Abstract][Full Text] [Related]
26. Effect of amantadine (Viregyt-K) on extrapyramidal symptoms of parkinsonian patients. Boczán G Ther Hung; 1974; 22(4):147-53. PubMed ID: 4465958 [No Abstract] [Full Text] [Related]
27. Parkinsonism and tardive dyskinesia after chronic use of clebopride. Sempere AP; Duarte J; Palomares JM; Coria F; Clavería LE Mov Disord; 1994 Jan; 9(1):114-5. PubMed ID: 8166880 [No Abstract] [Full Text] [Related]
31. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. Rich SS; Friedman JH; Ott BR J Clin Psychiatry; 1995 Dec; 56(12):556-9. PubMed ID: 8530331 [TBL] [Abstract][Full Text] [Related]
32. Investigating levodopa-induced dyskinesias in the parkinsonian primate. Langston JW; Quik M; Petzinger G; Jakowec M; Di Monte DA Ann Neurol; 2000 Apr; 47(4 Suppl 1):S79-89. PubMed ID: 10762135 [TBL] [Abstract][Full Text] [Related]
33. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia. Nevet A; Morris G; Saban G; Fainstein N; Bergman H J Neurophysiol; 2004 Oct; 92(4):1973-81. PubMed ID: 15115785 [TBL] [Abstract][Full Text] [Related]
34. [Analysis and nursing care of extrapyramidal reactions caused by antipsychotics in 75 cases]. Li NP Zhonghua Hu Li Za Zhi; 1997 Feb; 32(2):84-6. PubMed ID: 9369564 [No Abstract] [Full Text] [Related]
36. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Vitek JL; Giroux M Ann Neurol; 2000 Apr; 47(4 Suppl 1):S131-40. PubMed ID: 10762140 [TBL] [Abstract][Full Text] [Related]
37. Neuronal basis of neuroleptic-induced extrapyramidal side effects. Ossowska K Pol J Pharmacol; 2002; 54(4):299-312. PubMed ID: 12523484 [TBL] [Abstract][Full Text] [Related]
38. Acute organophosphate poisoning presenting with choreo-athetosis. Joubert J; Joubert PH; van der Spuy M; van Graan E J Toxicol Clin Toxicol; 1984; 22(2):187-91. PubMed ID: 6209420 [TBL] [Abstract][Full Text] [Related]
39. Neutralization of extrapyramidal side-effects with Methixene. Maller O; Heller S Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695 [No Abstract] [Full Text] [Related]